For millions of people living with HIV, a daily regimen of medications is a lifelong necessity. If they stop taking the drugs ...

The most effective HIV treatments are those that fit into patients’ lives. With the right support, long-acting antiretroviral therapy can make it easier for underserved people with adherence barriers ...

Findings identify genes that may represent possible new targets for a "block and lock" strategy for curing HIV.

The human immunodeficiency virus (HIV), the virus that causes healthy adults to become immunosuppressed, integrates its viral genetic code into the genome of the immune CD4+ T cells. While ...

A major international randomized clinical trial has found that HIV-infected individuals have a considerably lower risk of developing AIDS or other serious illnesses if they start taking antiretroviral ...

Please provide your email address to receive an email when new articles are posted on . The International Antiviral Society–USA Panel recently published new recommendations for managing HIV, including ...

CLEVELAND, Ohio — A recent clinical trial led by the University of Cincinnati looked at whether people living with HIV were ...

Merck & Co. Inc. (NYSE: MRK) on Wednesday shared topline results from the Phase 3 trial of an investigational, once-daily, oral, two-drug, single-tablet regimen of doravirine/islatravir (DOR/ISL) in ...

People living with HIV need to take antiretroviral treatment for life to prevent the virus from multiplying in their body. But some people, known as 'post-treatment controllers,' have been able to ...

Two posters compared health care resource utilization (HCRU) and financial burdens of people living with HIV with a non-HIV population and people with HIV who are heavily treated with those have ...